Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Current Leases (2019 - 2025)

Marimed has reported Current Leases over the past 7 years, most recently at $2.1 million for Q4 2025.

  • Quarterly Current Leases rose 5.23% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 5.23% year-over-year, with the annual reading at $2.1 million for FY2025, 5.23% up from the prior year.
  • Current Leases was $2.1 million for Q4 2025 at Marimed, down from $2.2 million in the prior quarter.
  • Over five years, Current Leases peaked at $2.2 million in Q3 2025 and troughed at $33453.0 in Q2 2021.
  • The 5-year median for Current Leases is $1.7 million (2023), against an average of $1.4 million.
  • Year-over-year, Current Leases plummeted 96.62% in 2021 and then soared 2980.45% in 2022.
  • A 5-year view of Current Leases shows it stood at $1.1 million in 2021, then tumbled by 77.87% to $237000.0 in 2022, then skyrocketed by 720.68% to $1.9 million in 2023, then grew by 2.21% to $2.0 million in 2024, then rose by 5.23% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Current Leases are $2.1 million (Q4 2025), $2.2 million (Q3 2025), and $2.0 million (Q2 2025).